Literature DB >> 1085940

The effects of intramyometrial injection of prostaglandin F2alpha on severe post-partum hemorrhage.

S Takagi, T Yoshida, Y Togo, H Tochigi, M Abe, H Sakata, T K Fujii, H Takahashi, B Tochigi.   

Abstract

Effectiveness of prostaglandin F2alpha (PGF2alpha) in controlling postpartum uterine hemorrhage was evaluated with the following results. (1) Systemic administration, whether by continuous i.v. infusion or by gluteal i.m. injection, was not a completely adequate method for hemostasis. (2) Local administration by directly injecting into the uterine musculature, whether transabdominally or transvaginally, resulted in a dramatic reduction of the rate of bleeding. Routine clinical application of the direct intramyometrial injection of PGF2alpha for severe post-partum hemorrhage is recommended in view of its easy performance, excellent hemostatic effect, minimal side effects and good prognosis.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1085940     DOI: 10.1016/0090-6980(76)90037-x

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  9 in total

1.  Cardiovascular collapse following an overdose of prostaglandin F2 alpha: a case report.

Authors:  M J Douglas; D F Farquharson; P L Ross; J E Renwick
Journal:  Can J Anaesth       Date:  1989-07       Impact factor: 5.063

Review 2.  Prostaglandins for preventing postpartum haemorrhage.

Authors:  Özge Tunçalp; G Justus Hofmeyr; A Metin Gülmezoglu
Journal:  Cochrane Database Syst Rev       Date:  2012-08-15

Review 3.  Treatment for primary postpartum haemorrhage.

Authors:  Hatem A Mousa; Jennifer Blum; Ghada Abou El Senoun; Haleema Shakur; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2014-02-13

4.  Anaesthetic management of patients with placenta accreta.

Authors:  A A Kamani; D R Gambling; J Christilaw; M L Flanagan
Journal:  Can J Anaesth       Date:  1987-11       Impact factor: 5.063

Review 5.  Ergot alkaloids. Current status and review of clinical pharmacology and therapeutic use compared with other oxytocics in obstetrics and gynaecology.

Authors:  A N de Groot; P W van Dongen; T B Vree; Y A Hekster; J van Roosmalen
Journal:  Drugs       Date:  1998-10       Impact factor: 9.546

6.  Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis.

Authors:  Ioannis D Gallos; Argyro Papadopoulou; Rebecca Man; Nikolaos Athanasopoulos; Aurelio Tobias; Malcolm J Price; Myfanwy J Williams; Virginia Diaz; Julia Pasquale; Monica Chamillard; Mariana Widmer; Özge Tunçalp; G Justus Hofmeyr; Fernando Althabe; Ahmet Metin Gülmezoglu; Joshua P Vogel; Olufemi T Oladapo; Arri Coomarasamy
Journal:  Cochrane Database Syst Rev       Date:  2018-12-19

7.  Uterotonic agents for first-line treatment of postpartum haemorrhage: a network meta-analysis.

Authors:  William R Parry Smith; Argyro Papadopoulou; Eleanor Thomas; Aurelio Tobias; Malcolm J Price; Shireen Meher; Zarko Alfirevic; Andrew D Weeks; G Justus Hofmeyr; Ahmet Metin Gülmezoglu; Mariana Widmer; Olufemi T Oladapo; Joshua P Vogel; Fernando Althabe; Arri Coomarasamy; Ioannis D Gallos
Journal:  Cochrane Database Syst Rev       Date:  2020-11-24

8.  The development of oxytocic drugs in the management of postpartum haemorrhage.

Authors:  Thomas F Baskett
Journal:  Ulster Med J       Date:  2004-05

Review 9.  Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis.

Authors:  Ioannis D Gallos; Helen M Williams; Malcolm J Price; Abi Merriel; Harold Gee; David Lissauer; Vidhya Moorthy; Aurelio Tobias; Jonathan J Deeks; Mariana Widmer; Özge Tunçalp; Ahmet Metin Gülmezoglu; G Justus Hofmeyr; Arri Coomarasamy
Journal:  Cochrane Database Syst Rev       Date:  2018-04-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.